div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=documenthome-gsk-at-31-december-2016-the-company-had-in-issue-7874858k-europeanhtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: Home GSK … · At 31 December 2016 the Company had in issue £7874858k European Medium Term Notes and £3214961k US Medium Term Notes 2015: £7333953k and £2708366k loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsinreader034viewer20220504075f841b9b3fb16612484d2a90html5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=documenthome-gsk-at-31-december-2016-the-company-had-in-issue-7874858k-europeanhtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: Home GSK … · At 31 December 2016 the Company had in issue £7874858k European Medium Term Notes and £3214961k US Medium Term Notes 2015: £7333953k and £2708366k loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsinreader034viewer20220504075f841b9b3fb16612484d2a90html5thumbnails2jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imageimg data-url=documenthome-gsk-at-31-december-2016-the-company-had-in-issue-7874858k-europeanhtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: Home GSK … · At 31 December 2016 the Company had in issue £7874858k European Medium Term Notes and £3214961k US Medium Term Notes 2015: £7333953k and £2708366k loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsinreader034viewer20220504075f841b9b3fb16612484d2a90html5thumbnails3jpg width=140...